Potential tissue-imaging agents: 23-(trimethyl [117mSn]stannyl)-24-nor-5 alpha-cholan-3 beta-ol

J Med Chem. 1983 Oct;26(10):1535-7. doi: 10.1021/jm00364a034.

Abstract

Tin-117m-labeled 23-(trimethylstannyl)-24-nor-5 alpha-cholan-3 beta-ol (2) has been prepared by reaction of trimethyl [117mSn]tin lithium with 3 beta-acetoxy-23-bromo-24-nor-5 alpha-cholane (1). Tin-117m (2) shows pronounced adrenal uptake (2.5% injected dose) in female rats 1 day after injection. Furthermore, the adrenal to liver (9.1:1) and adrenal to blood (33.7:1) ratios are high after this period. The absorbed radiation dose values from [117mSn]2 to human organs have also been estimated by using rat tissue distribution and excretion data. [117mSn]2 is the first reported tissue-specific organic radiopharmaceutical labeled with this nuclide and may have potential as an adrenal imaging agent.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adrenal Glands / metabolism
  • Animals
  • Cholanes / chemical synthesis*
  • Cholanes / metabolism
  • Female
  • Indicators and Reagents
  • Kidney / metabolism
  • Kinetics
  • Liver / metabolism
  • Male
  • Mass Spectrometry
  • Ovary / metabolism
  • Radioisotopes
  • Radionuclide Imaging / methods*
  • Rats
  • Spectrophotometry, Infrared
  • Tissue Distribution
  • Trialkyltin Compounds / chemical synthesis*
  • Trimethyltin Compounds / chemical synthesis*
  • Trimethyltin Compounds / metabolism

Substances

  • Cholanes
  • Indicators and Reagents
  • Radioisotopes
  • Trialkyltin Compounds
  • Trimethyltin Compounds
  • 23-(trimethylstannyl)-24-norcholan-3-ol